Atlas Trials

Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory

Clinical trial NCT00530257 · COMPLETED

Trial details

NCT number
NCT00530257
Sponsor
Children's Hospital of Philadelphia
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2004-06-01
Primary completion
2008-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.